Harvard Medical School receives $9M for rare cancer research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nine teams representing 19 lead and co-lead investigators across Harvard Medical School and its affiliated hospitals have received a total of over $9 million to research rare cares. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

When conducting a randomized clinical trial of a treatment regimen based on an immune checkpoint inhibitor, trial sponsors should include overall survival as an endpoint, FDA officials say.

Login